R&D is at the heart of fulfilling GlobalEx’s purpose as we work to translate advanced science and technologies into the water treatments and disinfecting that matter most.
Today, we are at a unique moment in chemical innovation. More than a decade after the first full treatment for water, we have a fundamentally better understanding of biocidal and virucidal technology and what causes disease. We have also learned that it takes more than just great science to deliver meaningful new answers. Over the last few years, GlobalEx has taken a hard look at the way we did R&D in the past. We have better integrated science and business, which meant transforming our approach to be more collaborative, more focused, and, we believe, more powerful for users. Ultimately, we’ve worked to design an engine that can deliver users a sustainable flow of important new technologies, year after year.
We focus our efforts in core areas where we believe GlobalEx is best positioned to bring unique, needed water and air treatment. This includes water global disinfecting, sterilization, air disinfecting in-door and out-door. We bring to these areas, cutting-edge capabilities in disinfecting and treatment design and development.
Key to our approach is collaborating in new and dynamic ways with other innovators across the health landscape including academic scientists, universities, governments, other chemicals companies. Today our pipeline is comprised of over 80 innovative treatments including legionelosis protocol, new sterilization protocol and new air disinfecting treatment. We are also building upon a heritage of developing safe and effective drinkable water treatment to introduce high-quality standards that can broaden costumer access with lower-cost alternative biocide treatment.